|
rdf:type |
|
|
lifeskim:mentions |
umls-concept:C0019069,
umls-concept:C0029237,
umls-concept:C0031831,
umls-concept:C0036576,
umls-concept:C0038137,
umls-concept:C0041700,
umls-concept:C0162791,
umls-concept:C0175675,
umls-concept:C0205099,
umls-concept:C0282423,
umls-concept:C0302350,
umls-concept:C0439660,
umls-concept:C0596227,
umls-concept:C1274119,
umls-concept:C1292734,
umls-concept:C1458140,
umls-concept:C1514468,
umls-concept:C1522326,
umls-concept:C1524063,
umls-concept:C1706842,
umls-concept:C2699414
|
|
pubmed:issue |
4
|
|
pubmed:dateCreated |
2009-1-15
|
|
pubmed:abstractText |
Evidence-based guidelines are presented on the selection and use of therapeutic products to treat haemophilia and other hereditary bleeding disorders. They include details of therapeutic products available in the UK and they update and replace previous United Kingdom Haemophilia Centre Doctors' Organisation guidelines.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Jul
|
|
pubmed:issn |
1365-2516
|
|
pubmed:author |
|
|
pubmed:issnType |
Electronic
|
|
pubmed:volume |
14
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
671-84
|
|
pubmed:dateRevised |
2009-10-21
|
|
pubmed:meshHeading |
pubmed-meshheading:18422612-Autoantibodies,
pubmed-meshheading:18422612-Blood Coagulation Disorders, Inherited,
pubmed-meshheading:18422612-Blood Coagulation Factors,
pubmed-meshheading:18422612-Blood-Borne Pathogens,
pubmed-meshheading:18422612-Coagulants,
pubmed-meshheading:18422612-Evidence-Based Medicine,
pubmed-meshheading:18422612-Hemophilia A,
pubmed-meshheading:18422612-Hemophilia B,
pubmed-meshheading:18422612-Humans,
pubmed-meshheading:18422612-Male,
pubmed-meshheading:18422612-Recombinant Proteins,
pubmed-meshheading:18422612-Thrombosis,
pubmed-meshheading:18422612-Virus Inactivation
|
|
pubmed:year |
2008
|
|
pubmed:articleTitle |
Guideline on the selection and use of therapeutic products to treat haemophilia and other hereditary bleeding disorders. A United Kingdom Haemophilia Center Doctors' Organisation (UKHCDO) guideline approved by the British Committee for Standards in Haematology.
|
|
pubmed:affiliation |
Oxford Haemophilia and Thrombosis Centre, Churchill Hospital, Oxford.
|
|
pubmed:publicationType |
Journal Article,
Practice Guideline
|
